Last updated on May 2018

A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus

Brief description of study

The purpose of this study is to evaluate the efficacy of ustekinumab in participants with active systemic lupus erythematosus (SLE) who have not adequately responded to one or more standard of care treatments.

Clinical Study Identifier: NCT03517722

Contact Investigators or Research Sites near you

Start Over

Study Contact

Winelands Medical Research Centre
Stellenbosch, South Africa
  Connect »